Using pharmacokinetic modelling to improve prescribing practices of intravenous aminophylline in childhood asthma exacerbations. (April 2017)
- Record Type:
- Journal Article
- Title:
- Using pharmacokinetic modelling to improve prescribing practices of intravenous aminophylline in childhood asthma exacerbations. (April 2017)
- Main Title:
- Using pharmacokinetic modelling to improve prescribing practices of intravenous aminophylline in childhood asthma exacerbations
- Authors:
- Cooney, Lewis
McBride, Antonia
Lilley, Andrew
Sinha, Ian
Johnson, Trevor N.
Hawcutt, Daniel B. - Abstract:
- Abstract: Objective: To evaluate physiologically based pharmacokinetic modelling (PBPK) software in paediatric asthma patients using intravenous aminophylline. Methods: Prospective clinical audit of children receiving iv aminophylline (July 2014 to June 2016), and in-silico modelling using Simcyp software. Results: Thirty-eight admissions (25 children) were included. Children with aminophylline levels ≥10 mg/l had equivalent clinical outcomes compared to those <10 mg/L, and adverse effects occurred in 57%. Therapeutic drug monitoring (TDM) data correlated well with PBPK model. PBPK modelling of a 5 mg/kg iv loading dose (≤18yr) shows a mean Cmax of 8.99 mg/L (5th-95th centiles 5.5–13.7 mg/L), with 70.3% of subjects <10 mg/L, 29.4% achieving 10-20 mg/L, and 0.1% > 20 mg/L. For an aminophylline infusion (0-12 y) of 1.0 mg/kg/h, the mean steady state infusion concentration was 16.4 mg/L, (5th-95th centiles 5.3–32 mg/L), with 26.8% having a serum concentration >20 mg/L. For 12-18yr receiving 0.5 mg/kg/h infusion, the mean steady state infusion concentration was 9.37 mg/L (5th-95th centiles 3.4–18 mg/L), with 59.8% having a serum concentration <10 mg/L. Conclusion: PBPK software modelling correlates well with clinical data. Current aminophylline iv loading dosage recommendations achieve levels <10 mg/l in 70% of children. Routine TDM may need altering as low risk of toxicity (>20 mg/l).
- Is Part Of:
- Pulmonary pharmacology & therapeutics. Volume 43(2017:Apr.)
- Journal:
- Pulmonary pharmacology & therapeutics
- Issue:
- Volume 43(2017:Apr.)
- Issue Display:
- Volume 43 (2017)
- Year:
- 2017
- Volume:
- 43
- Issue Sort Value:
- 2017-0043-0000-0000
- Page Start:
- 6
- Page End:
- 11
- Publication Date:
- 2017-04
- Subjects:
- Pharmacokinetics -- Aminophylline -- Paediatric -- PBPK modelling -- Dosing
Respiratory organs -- Diseases -- Chemotherapy -- Periodicals
615.7205 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10945539 ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/pulmonary-pharmacology-and-therapeutics/ ↗ - DOI:
- 10.1016/j.pupt.2017.01.007 ↗
- Languages:
- English
- ISSNs:
- 1094-5539
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7156.978500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2112.xml